Clinical Trial

Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol

Recruiting
View on ClinicalTrials.gov →
Summary
Ovarian endometriomas are cystic masses lined with endometrial tissue that contains fluid arising from a collection of menstrual debris. Ovarian endometriomas clinical manifestations includes pelvic pain, dysmenorrhea, dysfunctional uterine bleeding, and infertility. Endometriomas are most commonly treated either medically or by surgical excision. Ultrasonography (US)-guided aspiration and sclerotherapy is a new approach. Its mechanism of action is believed to be destruction of the inner epithelial lining, which is followed by inflammation and fibrosis, eventually resulting in regression of the cyst. The main advantage in this approach is the avoidance of collateral damage to the ovary.
Trial Details
NCT Number NCT06971458
Lead Sponsor Hillel Yaffe Medical Center
Conditions IVF, Endometrioma
Enrollment 120 participants
Start Date 2022-08-09
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-14